Jim Candler had a successful 40-year career in system operations before coming to Gilead three years ago to bring his tech expertise to the Human Resources team.
Quest Diagnostics Chairman, CEO, and President Steve Rusckowski was honored for his “exceptional contributions to humanism in healthcare by the prestigious Arnold P. Gold Foundation.
The Coronavirus sent the world into a tailspin a little over two years ago. Due to the airborne qualities of the virus, it ignited interest and concern over air quality. COVID aided in demonstrating the connection between air quality and human health.
Illumina, Inc. announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator with the aim to advance breakthroughs in human health.
Predominantly Black and Hispanic lower-income communities are experiencing some of the most devastating impacts of the pandemic. Upon the launch of Q4HE, these vulnerable communities were the first priority.
Q4HE provided Cedarbrook with COVID-19 PCR testing for 600 staff members and 500 residents at their facility, with twice-weekly collections over a 12-week period—offering much-needed support to some of the most vulnerable members of the population.
As Kimberly-Clark celebrates 150 years of providing Better Care for a Better World, the Kimberly-Clark Foundation announced that it will honor this milestone anniversary by awarding three $150,000 grants to global nonprofit organizations.
This March, Australia launched the Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT), which will sequence the genomes of more than 20,000 cancer patients, many with rare and challenging tumors.
FedEx Cares is our global community engagement program and one way we connect people and possibilities.We support nonprofit organizations working to...
The SCS Kingfisher certification mark is showing up on an increasing number of products around the world. It differentiates companies that are making...
